US28: HCMV's Swiss Army Knife

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
foscarnet 1 infectiousdiseasesdrugs
ganciclovir 4 infectiousdiseasesdrugs

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
foscarnet 2309 significant risk. In these cases, HCMV-associated disease is treated with antivirals such as ganciclovir, foscarnet , or letermovir [[4]], which are effective against lytically replicating virus. However, these treatments
ganciclovir 2296 that pose significant risk. In these cases, HCMV-associated disease is treated with antivirals such as ganciclovir , foscarnet, or letermovir [[4]], which are effective against lytically replicating virus. However, these
ganciclovir 34340 patients [[126]]. Targeting HCMV has also showed promise for GBM patients, who when treated with val ganciclovir in addition to standard care had an improved two year survival rate of 62% compared to 18% for the control
ganciclovir 34588 study [[127]] and median overall survival increased from 8.7 to 13.1 months in another study, where val ganciclovir was provided with the antiangiogenic antibody, bevacizumab [[128]]. It is important to note that each
ganciclovir 35936 also failed to find a link between CMV and gliomas [[137]]. Indeed, one study treating GBM with val ganciclovir as an add-on therapy had disappointing results [[138]]. Links between CMV and other cancers, such as
Select Disease Character Offset Disease Term Instance

You must be authorized to submit a review.